{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:55Z","timestamp":1792783495947,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Canadian Institutes of Health Research"],"award-info":[{"award-number":["Canadian Institutes of Health Research"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["Natural Sciences and Engineering Research Council of Canada"],"award-info":[{"award-number":["Natural Sciences and Engineering Research Council of Canada"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ontario Graduate Scholarship","award":["Ontario Graduate Scholarship"],"award-info":[{"award-number":["Ontario Graduate Scholarship"]}]},{"DOI":"10.13039\/100010449","name":"Ministry of Education, Libya","doi-asserted-by":"publisher","award":["Ministry of Education, Libya"],"award-info":[{"award-number":["Ministry of Education, Libya"]}],"id":[{"id":"10.13039\/100010449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ontario Graduate Scholarship","award":["Ontario Graduate Scholarship"],"award-info":[{"award-number":["Ontario Graduate Scholarship"]}]},{"name":"Chinese Council of Scholarship","award":["Chinese Council of Scholarship"],"award-info":[{"award-number":["Chinese Council of Scholarship"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s13346-025-01873-1","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:19:40Z","timestamp":1747653580000},"page":"180-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mitigating radioresistance mechanisms by polymer-lipid manganese dioxide nanoparticles enhances immunogenic cell death and antitumor immune response to facilitate abscopal effect in breast tumor models"],"prefix":"10.1007","volume":"16","author":[{"given":"HoYin","family":"Lip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmottaleb","family":"Zetrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliya","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar Z.","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Alradwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Rauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-8115","authenticated-orcid":false,"given":"Xiao Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"12","key":"1873_CR1","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1097\/PAS.0000000000000749","volume":"40","author":"MA Duggan","year":"2016","unstructured":"Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The surveillance, epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship. Am J Surg Pathol. 2016;40(12):e94\u2013102.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1873_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/curroncol31030090","volume":"31","author":"I Kol\u00e1\u0159ov\u00e1","year":"2024","unstructured":"Kol\u00e1\u0159ov\u00e1 I, Melichar B, Sir\u00e1k I, Va\u0148\u00e1sek J, Petera J, Hor\u00e1\u010dkov\u00e1 K, et al. The role of adjuvant radiotherapy in the treatment of breast Cancer. Curr Oncol. 2024;31(3):1207\u201320.","journal-title":"Curr Oncol"},{"issue":"8","key":"1873_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MM, Kay J, Mueller SN, et al. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24(8):554\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1873_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","volume":"8","author":"S Guo","year":"2023","unstructured":"Guo S, Yao Y, Tang Y, Xin Z, Wu D, Ni C, et al. Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduct Target Therapy. 2023;8(1):205.","journal-title":"Signal Transduct Target Therapy"},{"key":"1873_CR5","doi-asserted-by":"crossref","unstructured":"Beckers C, Pruschy M, Vetrugno I. Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities. Seminars in Cancer Biology; Elsevier; 2024.","DOI":"10.1016\/j.semcancer.2023.11.006"},{"issue":"1","key":"1873_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/imr.13251","volume":"321","author":"Y Xi","year":"2024","unstructured":"Xi Y, Chen L, Tang J, Yu B, Shen W, Niu X. Amplifying eat me signal by Immunogenic cell death for potentiating cancer immunotherapy. Immunol Rev. 2024;321(1):94\u2013114.","journal-title":"Immunol Rev"},{"issue":"1","key":"1873_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-023-04017-6","volume":"21","author":"L Galluzzi","year":"2023","unstructured":"Galluzzi L, Kepp O, Hett E, Kroemer G, Marincola FM. Immunogenic cell death in cancer: concept and therapeutic implications. J Translational Med. 2023;21(1):162.","journal-title":"J Translational Med"},{"key":"1873_CR8","doi-asserted-by":"crossref","unstructured":"Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Targeting Immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discovery. 2024:1\u201316.","DOI":"10.1038\/s41573-024-00920-9"},{"key":"1873_CR9","doi-asserted-by":"crossref","unstructured":"Pan H, Liu P, Zhao L, Pan Y, Mao M, Kroemer G, et al. Immunogenic cell stress and death in the treatment of cancer. Seminars in Cell & Developmental Biology; Elsevier; 2024.","DOI":"10.1016\/j.semcdb.2023.10.007"},{"issue":"4","key":"1873_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nri.2017.9","volume":"17","author":"N Yatim","year":"2017","unstructured":"Yatim N, Cullen S, Albert ML. Dying cells actively regulate adaptive immune responses. Nat Rev Immunol. 2017;17(4):262\u201375.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1873_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41416-020-0942-3","volume":"123","author":"E Daguenet","year":"2020","unstructured":"Daguenet E, Louati S, Wozny A, Vial N, Gras M, Guy J, et al. Radiation-induced bystander and abscopal effects: important lessons from preclinical models. Br J Cancer. 2020;123(3):339\u201348.","journal-title":"Br J Cancer"},{"issue":"13","key":"1873_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2217\/fon-2020-0994","volume":"17","author":"DJ Craig","year":"2021","unstructured":"Craig DJ, Nanavaty NS, Devanaboyina M, Stanbery L, Hamouda D, Edelman G, et al. The abscopal effect of radiation therapy. Future Oncol. 2021;17(13):1683\u201394.","journal-title":"Future Oncol"},{"key":"1873_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.lungcan.2020.02.015","volume":"142","author":"WS Theelen","year":"2020","unstructured":"Theelen WS, de Jong MC, Baas P. Synergizing systemic responses by combining immunotherapy with radiotherapy in metastatic non-small cell lung cancer: the potential of the abscopal effect. Lung Cancer. 2020;142:106\u201313.","journal-title":"Lung Cancer"},{"key":"1873_CR14","doi-asserted-by":"publisher","first-page":"1409300","DOI":"10.3389\/fmolb.2024.1409300","volume":"11","author":"G Dagar","year":"2024","unstructured":"Dagar G, Gupta A, Shankar A, Chauhan R, Macha MA, Bhat AA, et al. The future of cancer treatment: combining radiotherapy with immunotherapy. Front Mol Biosci. 2024;11:1409300.","journal-title":"Front Mol Biosci"},{"key":"1873_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","volume":"11","author":"A Labani-Motlagh","year":"2020","unstructured":"Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol. 2020;11:940.","journal-title":"Front Immunol"},{"issue":"10","key":"1873_CR16","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K. Reactive oxygen species in cancer: current findings and future directions. Cancer Sci. 2021;112(10):3945\u201352.","journal-title":"Cancer Sci"},{"key":"1873_CR17","doi-asserted-by":"publisher","first-page":"840029","DOI":"10.3389\/fimmu.2022.840029","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Liu G, Li Y, Pan Y. Metabolic reprogramming induces macrophage polarization in the tumor microenvironment. Front Immunol. 2022;13:840029.","journal-title":"Front Immunol"},{"issue":"12","key":"1873_CR18","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.3390\/ijms22126526","volume":"22","author":"MT Munir","year":"2021","unstructured":"Munir MT, Kay MK, Kang MH, Rahman MM, Al-Harrasi A, Choudhury M, et al. Tumor-associated macrophages as multifaceted regulators of breast tumor growth. Int J Mol Sci. 2021;22(12):6526.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1873_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","volume":"41","author":"C Tay","year":"2023","unstructured":"Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023;41(3):450\u201365.","journal-title":"Cancer Cell"},{"key":"1873_CR20","doi-asserted-by":"publisher","first-page":"1175532","DOI":"10.3389\/fonc.2023.1175532","volume":"13","author":"SS Mortazavi Farsani","year":"2023","unstructured":"Mortazavi Farsani SS, Verma V. Lactate mediated metabolic crosstalk between cancer and immune cells and its therapeutic implications. Front Oncol. 2023;13:1175532.","journal-title":"Front Oncol"},{"key":"1873_CR21","doi-asserted-by":"publisher","first-page":"0247","DOI":"10.34133\/research.0247","volume":"6","author":"AE Zetrini","year":"2023","unstructured":"Zetrini AE, Lip H, Abbasi AZ, Alradwan I, Ahmed T, He C, et al. Remodeling tumor immune microenvironment by using polymer-lipid-manganese dioxide nanoparticles with radiation therapy to boost immune response of castration-resistant prostate cancer. Research. 2023;6:0247.","journal-title":"Research"},{"issue":"11","key":"1873_CR22","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","volume":"72","author":"A Calcinotto","year":"2012","unstructured":"Calcinotto A, Filipazzi P, Grioni M, Iero M, De Milito A, Ricupito A, et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 2012;72(11):2746\u201356.","journal-title":"Cancer Res"},{"issue":"12","key":"1873_CR23","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/ni.3868","volume":"18","author":"T Maj","year":"2017","unstructured":"Maj T, Wang W, Crespo J, Zhang H, Wang W, Wei S, et al. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol. 2017;18(12):1332\u201341.","journal-title":"Nat Immunol"},{"key":"1873_CR24","doi-asserted-by":"crossref","unstructured":"Roux C, Jafari SM, Shinde R, Duncan G, Cescon DW, Silvester J et al. Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1. Proceedings of the National Academy of Sciences. 2019;116(10):4326\u201335.","DOI":"10.1073\/pnas.1819473116"},{"issue":"11","key":"1873_CR25","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1016\/j.ymthe.2024.08.019","volume":"32","author":"Y Jo","year":"2024","unstructured":"Jo Y, Shim JA, Jeong JW, Kim H, Lee SM, Jeong J, et al. Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8 T and CAR-T cells. Mol Ther. 2024;32(11):3879\u201394.","journal-title":"Mol Ther"},{"key":"1873_CR26","doi-asserted-by":"publisher","first-page":"110978","DOI":"10.1016\/j.biopha.2020.110978","volume":"133","author":"L Wang","year":"2021","unstructured":"Wang L, Kuang Z, Zhang D, Gao Y, Ying M, Wang T. Reactive oxygen species in immune cells: A new antitumor target. Biomed Pharmacother. 2021;133:110978.","journal-title":"Biomed Pharmacother"},{"issue":"22","key":"1873_CR27","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-15-3475","volume":"76","author":"AZ Abbasi","year":"2016","unstructured":"Abbasi AZ, Gordijo CR, Amini MA, Maeda A, Rauth AM, DaCosta RS, et al. Hybrid manganese dioxide nanoparticles potentiate radiation therapy by modulating tumor hypoxia. Cancer Res. 2016;76(22):6643\u201356.","journal-title":"Cancer Res"},{"issue":"12","key":"1873_CR28","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/adfm.201404511","volume":"25","author":"CR Gordijo","year":"2015","unstructured":"Gordijo CR, Abbasi AZ, Amini MA, Lip HY, Maeda A, Cai P, et al. Design of hybrid MnO2-Polymer\u2010Lipid nanoparticles with tunable oxygen generation rates and tumor accumulation for Cancer treatment. Adv Funct Mater. 2015;25(12):1858\u201372.","journal-title":"Adv Funct Mater"},{"issue":"4","key":"1873_CR29","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1021\/nn405773r","volume":"8","author":"P Prasad","year":"2014","unstructured":"Prasad P, Gordijo CR, Abbasi AZ, Maeda A, Ip A, Rauth AM, et al. Multifunctional albumin\u2013MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. ACS Nano. 2014;8(4):3202\u201312.","journal-title":"ACS Nano"},{"issue":"5 Pt 2","key":"1873_CR30","first-page":"831","volume":"27","author":"S Rockwell","year":"1977","unstructured":"Rockwell S. In vivo-in vitro tumor systems: new models for studing the response of tumours to therapy. Lab Anim Sci. 1977;27(5 Pt 2):831\u201351.","journal-title":"Lab Anim Sci"},{"issue":"4","key":"1873_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/cmi.2012.69","volume":"10","author":"D Lv","year":"2013","unstructured":"Lv D, Zhang Y, Kim H, Zhang L, Ma X. CCL5 as a potential immunotherapeutic target in triple-negative breast cancer. Cell Mol Immunol. 2013;10(4):303\u201310.","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"1873_CR32","first-page":"1486","volume":"58","author":"BA Pulaski","year":"1998","unstructured":"Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7. 1 cell-based tumor vaccines. Cancer Res. 1998;58(7):1486\u201393.","journal-title":"Cancer Res"},{"key":"1873_CR33","doi-asserted-by":"crossref","unstructured":"Muz B, De La Puente P, Azab F, Kareem Azab A. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia. 2015:83\u201392.","DOI":"10.2147\/HP.S93413"},{"key":"1873_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jchromb.2015.11.052","volume":"1019","author":"G Colombo","year":"2016","unstructured":"Colombo G, Clerici M, Garavaglia ME, Giustarini D, Rossi R, Milzani A, et al. A step-by-step protocol for assaying protein carbonylation in biological samples. J Chromatogr B. 2016;1019:178\u201390.","journal-title":"J Chromatogr B"},{"key":"1873_CR35","first-page":"934116","volume":"27","author":"W Boulefour","year":"2021","unstructured":"Boulefour W, Rowinski E, Louati S, Sotton S, Wozny A, Moreno-Acosta P, et al. A review of the role of hypoxia in radioresistance in cancer therapy. Med Sci Monitor: Int Med J Experimental Clin Res. 2021;27:934116.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"key":"1873_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.radonc.2022.02.026","volume":"170","author":"H Lip","year":"2022","unstructured":"Lip H, Amini MA, Zetrini A, Cai P, Abbasi AZ, Bristow RG, et al. Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts. Radiother Oncol. 2022;170:213\u201323.","journal-title":"Radiother Oncol"},{"issue":"9","key":"1873_CR37","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/stem.3391","volume":"39","author":"M R\u00fcckert","year":"2021","unstructured":"R\u00fcckert M, Flohr A, Hecht M, Gaipl US. Radiotherapy and the immune system: more than just immune suppression. Stem Cells. 2021;39(9):1155\u201365.","journal-title":"Stem Cells"},{"issue":"13","key":"1873_CR38","doi-asserted-by":"publisher","first-page":"7208","DOI":"10.3390\/ijms25137208","volume":"25","author":"L Yang","year":"2024","unstructured":"Yang L, Hu Q, Huang T. Breast Cancer treatment strategies targeting the tumor microenvironment: how to convert cold tumors to hot tumors. Int J Mol Sci. 2024;25(13):7208.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1873_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/cancers12030738","volume":"12","author":"RK Vaddepally","year":"2020","unstructured":"Vaddepally RK, Kharel P, Pandey R, Garje R, Chandra AB. Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence. Cancers. 2020;12(3):738.","journal-title":"Cancers"},{"issue":"4","key":"1873_CR40","doi-asserted-by":"publisher","first-page":"045209","DOI":"10.1088\/2057-1976\/1\/4\/045209","volume":"1","author":"DR Grimes","year":"2015","unstructured":"Grimes DR, Partridge M. A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio. Biomedical Phys Eng Express. 2015;1(4):045209.","journal-title":"Biomedical Phys Eng Express"},{"issue":"2","key":"1873_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2307\/3573534","volume":"53","author":"S Rockwell","year":"1973","unstructured":"Rockwell S, Kallman RF. Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. Radiat Res. 1973;53(2):281\u201394.","journal-title":"Radiat Res"},{"issue":"33","key":"1873_CR42","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1002\/adma.201602111","volume":"28","author":"G Song","year":"2016","unstructured":"Song G, Chen Y, Liang C, Yi X, Liu J, Sun X, et al. Catalase-Loaded TaOx nanoshells as Bio-Nanoreactors combining High-Z element and enzyme delivery for enhancing radiotherapy. Adv Mater (Deerfield Beach Fla). 2016;28(33):7143\u20138.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"1873_CR43","doi-asserted-by":"publisher","first-page":"119405","DOI":"10.1016\/j.biomaterials.2019.119405","volume":"220","author":"Y Wang","year":"2019","unstructured":"Wang Y, Song S, Lu T, Cheng Y, Song Y, Wang S, et al. Oxygen-supplementing mesoporous polydopamine nanosponges with WS2 QDs-embedded for CT\/MSOT\/MR imaging and thermoradiotherapy of hypoxic cancer. Biomaterials. 2019;220:119405.","journal-title":"Biomaterials"},{"key":"1873_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.05.025","volume":"138","author":"R Zhang","year":"2017","unstructured":"Zhang R, Song X, Liang C, Yi X, Song G, Chao Y, et al. Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer. Biomaterials. 2017;138:13\u201321.","journal-title":"Biomaterials"},{"issue":"42","key":"1873_CR45","doi-asserted-by":"publisher","first-page":"15069","DOI":"10.1002\/anie.201906758","volume":"58","author":"Y Yang","year":"2019","unstructured":"Yang Y, Chen M, Wang B, Wang P, Liu Y, Zhao Y, et al. NIR-II driven plasmon\u2010enhanced catalysis for a timely supply of oxygen to overcome hypoxia\u2010induced radiotherapy tolerance. Angew Chem Int Ed. 2019;58(42):15069\u201375.","journal-title":"Angew Chem Int Ed"},{"issue":"2","key":"1873_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijrobp.2015.01.026","volume":"92","author":"M Heravi","year":"2015","unstructured":"Heravi M, Kumala S, Rachid Z, Jean-Claude BJ, Radzioch D, Muanza TM. ZRBA1, a mixed EGFR\/DNA targeting molecule, potentiates radiation response through delayed DNA damage repair process in a triple negative breast cancer model. Int J Radiation Oncology* Biology* Phys. 2015;92(2):399\u2013406.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"19","key":"1873_CR47","doi-asserted-by":"publisher","first-page":"195007","DOI":"10.1088\/1361-6560\/ab2154","volume":"64","author":"A Rajaee","year":"2019","unstructured":"Rajaee A, Wang S, Zhao L, Wang D, Liu Y, Wang J, et al. Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging. Phys Med Biol. 2019;64(19):195007.","journal-title":"Phys Med Biol"},{"issue":"21","key":"1873_CR48","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1158\/1078-0432.CCR-11-0544","volume":"17","author":"F Bouquet","year":"2011","unstructured":"Bouquet F, Pal A, Pilones KA, Demaria S, Hann B, Akhurst RJ, et al. TGF\u03b21 Inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin Cancer Res. 2011;17(21):6754\u201365.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1873_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/jmss.JMSS_25_18","volume":"9","author":"F Raeisi","year":"2019","unstructured":"Raeisi F, Shahbazi-Gahrouei D, Raeisi E, Heidarian E. Evaluation of the radiosensitizing potency of Bromelain for radiation therapy of 4T1 breast cancer cells. J Med Signals Sens. 2019;9(1):68\u201374.","journal-title":"J Med Signals Sens"},{"key":"1873_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-018-1040-z","volume":"13","author":"CM Van Leeuwen","year":"2018","unstructured":"Van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken N, Stalpers L, et al. The Alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol. 2018;13:1\u201311.","journal-title":"Radiat Oncol"},{"key":"1873_CR51","doi-asserted-by":"crossref","unstructured":"Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB et al. Consensus guidelines for the definition, detection and interpretation of Immunogenic cell death. J Immunother Cancer. 2020;8(1).","DOI":"10.1136\/jitc-2019-000337corr1"},{"issue":"1","key":"1873_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31(1):51\u201372.","journal-title":"Annu Rev Immunol"},{"key":"1873_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-015-0621-0","volume":"17","author":"S Sousa","year":"2015","unstructured":"Sousa S, Brion R, Lintunen M, Kronqvist P, Sandholm J, M\u00f6nkk\u00f6nen J, et al. Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res. 2015;17:1\u201314.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1873_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1365-2249.2000.01105.x","volume":"119","author":"B Melichar","year":"2000","unstructured":"Melichar B, Nash MA, Lenzi R, Platsoucas CD, Freedman RS. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant Ascites CD3 tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Clin Experimental Immunol. 2000;119(1):19\u201327.","journal-title":"Clin Experimental Immunol"},{"issue":"5","key":"1873_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","volume":"24","author":"F Klug","year":"2013","unstructured":"Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, et al. Low-dose irradiation programs macrophage differentiation to an iNOS \/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell. 2013;24(5):589\u2013602.","journal-title":"Cancer Cell"},{"issue":"11","key":"1873_CR56","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368.","journal-title":"Nat Rev Immunol"},{"key":"1873_CR57","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10549-011-1647-3","volume":"130","author":"F Liu","year":"2011","unstructured":"Liu F, Lang R, Zhao J, Zhang X, Pringle GA, Fan Y, et al. CD8 cytotoxic T cell and FOXP3 regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat. 2011;130:645\u201355.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1873_CR58","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","volume":"11","author":"S Demaria","year":"2005","unstructured":"Demaria S, Kawashima N, Yang AM, Devitt ML, Babb JS, Allison JP, et al. Immune-mediated Inhibition of metastases after treatment with local radiation and CTLA-4 Blockade in a mouse model of breast cancer. Clin Cancer Res. 2005;11(2):728\u201334.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1873_CR59","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","volume":"18","author":"W Ngwa","year":"2018","unstructured":"Ngwa W, Irabor OC, Schoenfeld JD, Hesser J, Demaria S, Formenti SC. Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018;18(5):313\u201322.","journal-title":"Nat Rev Cancer"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01873-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T23:02:16Z","timestamp":1765148536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01873-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01873-1","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"5 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures strictly complied with the ethical and legal requirements under Ontario\u2019s Animals for Research Act and the Federal Canadian Council on Animal Care guidelines for the care and use of laboratory animals and were approved by the UHN Animal Care Committee (Animal Use Protocol 5880; UHN, Toronto, ON, CA).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No subjects were used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}